KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) EBT Margin: 2020-2025

Historic EBT Margin for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to -207.93%.

  • Ginkgo Bioworks Holdings' EBT Margin fell 14417.00% to -207.93% in Q3 2025 from the same period last year, while for Sep 2025 it was -188.29%, marking a year-over-year increase of 11065.00%. This contributed to the annual value of -241.15% for FY2024, which is 11396.00% up from last year.
  • Ginkgo Bioworks Holdings' EBT Margin amounted to -207.93% in Q3 2025, which was down 70.25% from -122.13% recorded in Q2 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' EBT Margin peaked at -63.76% during Q3 2024, and registered a low of -1,081.31% during Q4 2021.
  • Moreover, its 3-year median value for EBT Margin was -245.99% (2024), whereas its average is -297.83%.
  • Its EBT Margin has fluctuated over the past 5 years, first crashed by 93,660bps in 2021, then surged by 89,018bps in 2022.
  • Ginkgo Bioworks Holdings' EBT Margin (Quarterly) stood at -1,081.31% in 2021, then surged by 89,018bps to -191.13% in 2022, then plummeted by 41,855bps to -609.67% in 2023, then spiked by 36,368bps to -245.99% in 2024, then slumped by 14,417bps to -207.93% in 2025.
  • Its last three reported values are -207.93% in Q3 2025, -122.13% for Q2 2025, and -188.06% during Q1 2025.